MINNEAPOLIS–Stratasys (NASDAQ: SSYS) announces the availability of ABS-M30i, a new biocompatible material for use with its FDM 400mcTM prototyping and production system.
ABS-M30i is available for medical, food, and
pharmaceutical prototyping and production
Stratasys expects common prototyping and production applications to include surgical instruments, food processing and packaging systems, and pharmaceutical handling, processing, and packaging applications. ABS-M30i is FDA compatible and meets ISO 10993 standards. The material may be sterilized using either the gamma radiation or ethylene oxide (EtO) method.
ABS-M30i is available for medical, food, and pharmaceutical prototyping and production applications.
In addition to being biocompatible, ABS-M30i offers substantial improvements over standard Stratasys ABS across a number of mechanical properties, including tensile strength, impact strength, and flexural strength. ABS-M30i mechanical properties for strength are up to 67 percent stronger than standard Stratasys ABS, and bonding strength between layers is more than doubled, greatly expanding capabilities for functional testing or manufacturing production parts.
Build speeds using ABS-M30i on the Stratasys FDM 400mc are 29 percent faster, on average, than the same part built in ABS on a Stratasys FDM Titan, Vantage SE or Vantage S system. ABS-M30i also uses the new SR20 soluble support technology, enabling automated support-material removal. In addition, ABS-M30i parts can be built with 0.005, 0.007, 0.010, and 0.013 inch slices. It is initially available in “natural” off-white color.